Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-025425

Allena Pharmaceuticals, Inc. · ALNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
Period of report
Nov 6, 2017
Accepted (ET)
Nov 6, 2017 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624658

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Nov 6, 2017C2,575,964—A2,575,964D
Common StockF3Nov 6, 2017P215,000$14.00A2,790,964D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF3,F2—Nov 6, 2017C6,122,448D——Common Stock1,466,8050D
Series B Preferred StockF3,F2—Nov 6, 2017C4,629,630D——Common Stock1,109,1590D

Explanation of responses